Pictet Asset Management (UK)’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Pictet Asset Management (UK)’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-91,513	Closed	-$3.95M	–	911
2015 Q1	$3.95M	Sell	91,513 -12,926	-12%	-$498K	0.02%	634
2014 Q4	$3.52M	Buy	104,439 +1,989	+2%	+$70.2K	0.02%	663
2014 Q3	$3.59M	Buy	102,450 +68,063	+198%	+$2.33M	0.02%	626
2014 Q2	$1.13M	Buy	34,387 +8,229	+31%	+$282K	0.01%	781
2014 Q1	$964K	Sell	26,158 -14,004	-35%	-$514K	﹤0.01%	787
2013 Q4	$1.54M	Buy	+40,162	New	+$1.27M	0.01%	761

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Pictet Asset Management (UK)'s WX Position: Q2 2015 in Review

Pictet Asset Management (UK) sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 91,513 shares — an estimated $3.95M sold.

Pictet Asset Management (UK) first reported a position in WX in Q4 2013 and held it in 6 quarters. The position peaked at $3.95M in Q1 2015. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

Pictet Asset Management (UK) reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
Pictet Asset Management (UK) sold 91,513 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $3.95M.
Pictet Asset Management (UK) first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 6 quarters.
Pictet Asset Management (UK)'s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $3.95M in Q1 2015.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2015, filed 13 Aug 2015.